Clinical trial
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU…
NCT00053378 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00053378 |
|---|---|
| Title | A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects |
| Official title | A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypocalcemia |
| Intervention type | Behavioral, Drug |
| Interventions | paricalcitol injection (Zemplar), Effects on calcium regulation, Administration of elemental Ca during hypocalcemic ICU pts. |
| Enrollment | 45 |
| Start date | Jan 1, 2002 |
| First posted | Jan 28, 2003 |
| Last update posted | Aug 2, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: